Literature DB >> 2416338

Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor.

R R Lobb, E M Alderman, J W Fett.   

Abstract

The angiogenic capacity of the class 1 heparin-binding growth factor from bovine brain, an anionic endothelial cell mitogen of Mr 16 000, has been evaluated. Its ability to induce the growth of new blood vessels has been assessed by means of two established assay systems. On the embryonic chick chorioallantoic membrane dose-response studies demonstrate that 160 ng (10 pmol) of mitogen is required to induce angiogenesis in greater than 50% of the eggs within 72 h. In the presence of 1 unit of exogenous heparin only 40 ng of mitogen (2.5 pmol) is needed to induce a similar response. Moreover, this occurs within 48 h, indicating that heparin also augments the angiogenic response by enhancing the rate of induction of angiogenesis. Eighty nanograms (5 pmol) of mitogen also induces the ingrowth of new blood vessels into the rabbit cornea, both in the presence and in the absence of heparin. These results establish that the class 1 heparin-binding growth factor from bovine brain is an angiogenesis factor. Importantly, the neovascularization induced by this angiogenesis factor is enhanced by heparin. The mechanistic implications for neovascularization under certain normal and pathological conditions are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416338     DOI: 10.1021/bi00340a001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Studies on the effects of carriers, PBS, angiogenin, and bFGF.

Authors:  J Wilting; B Christ; M Bokeloh
Journal:  Anat Embryol (Berl)       Date:  1991

3.  Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures.

Authors:  R A Brooks; J M Burrin; E M Kohner
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  Localization of the human angiogenin gene to chromosome band 14q11, proximal to the T cell receptor alpha/delta locus.

Authors:  S Weremowicz; E A Fox; C C Morton; B L Vallee
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

Review 5.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

6.  Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?

Authors:  Jennifer T Durham; Brian M Dulmovits; Stephen M Cronk; Anthony R Sheets; Ira M Herman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

7.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Cloning of the gene coding for human class 1 heparin-binding growth factor and its expression in fetal tissues.

Authors:  W P Wang; K Lehtoma; M L Varban; I Krishnan; I M Chiu
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

Review 9.  Mesoderm induction and blood island formation by angiogenic growth factors and embryonic inducing factors.

Authors:  W Knöchel; H Grunz; B Loppnow-Blinde; H Tiedemann; H Tiedemann
Journal:  Blut       Date:  1989-09

10.  Embryonic chick muscle produces an FGF-like activity.

Authors:  D S Morris; S J Stock; J C McLachlan
Journal:  Experientia       Date:  1996-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.